| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > A Definition Of Yield Management |
|
Digg It - A Definition Of Yield Management
Yield Management:
A yield management system, which can also be referred to According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product as revenue management, is a system that attempts to understand, anticipate and then react to consume ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r behaviour in order to maximise revenue/profit. How Does Yield Management Work? lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. o acheive maximum revenue/profit, a yield management system needs to have an understanding of what h here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe as happened before and what is happening now; using this historical data to predict what may then ha d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ppen in the future. So the yield management system will periodically review transactions that have o ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc curred between the consumer and the hotel. Other external information is then fed into the yield man easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi agement system and this can include statistical data, events such as public holidays, competitor pri nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ce information, seasonal buying patterns, etc. A predictive modeller then attempts to forecast the t and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ tal demand within a specific period for the services on offer by market segment and price point. In ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi simple terms yield management tries to answer the question "Given our operating constraints, what i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s the best mix of services for us to sell within a particular timeframe, so that we generate the hig dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod est revenue?" The process of yield management optimisation helps an organisation to adjust its pric cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin es so that they meet the total demand characteristics of its markets. In order to maximise the reven tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ue, prices can be determined by:
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel onsumer type or geographical)
Yield management mode ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ls are most effective where the service being supplied is characterised as:
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products sive
. As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de in time)
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip terised with:
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Ways To Jumpstart Your IT Career How Home-Based Business Entrepreneurs Think
|